Medium-term Outcomes of Unsutured Scleral Flap Trabeculectomies

J Glaucoma. 2016 Aug;25(8):704-8. doi: 10.1097/IJG.0000000000000405.

Abstract

Purpose: To examine the clinical characteristics and medium-term outcomes of unsutured scleral flap trabeculectomies.

Patient and methods: A retrospective review of 45 patients who underwent 50 unsutured scleral flap trabeculectomies by a single ophthalmic surgeon. Information pertaining to each patient's demographic details, preoperative assessment, surgical procedure, and 2 years of postoperative management were obtained.

Results: The average age of patients was 72.4±12.5 (range, 30 to 97) years. The diagnosis was primary open-angle glaucoma in 38 (76.0%) cases. The average preoperative, 1 year postoperative and 2-year postoperative intraocular pressure (with number of topical antiglaucoma medications) were 20.8 (2.5), 13.2 (0.4), and 12.6 mm Hg (0.7), respectively. The procedure performed was a trabeculectomy alone in 32 (64.0%) cases, and combined trabeculectomy and phacoemulsification in 18 (36.0%) cases. Four were performed with mitomycin C. Three procedures (6%) had intraoperative complications (2 iris prolapses, 1 subconjunctival hemorrhage). Seven procedures were complicated by a postoperative choroidal detachment, which were managed conservatively and resolved spontaneously over time. There was 1 case (2%) of postoperative hypotony, which failed to resolve (intraocular pressure of <6 mm Hg for >3 months).

Conclusions: The majority of unsutured scleral flap trabeculectomies had an acceptable risk profile and resulted in a decrease in the intraocular pressure at 2 years postoperatively.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Conjunctival Diseases / drug therapy
  • Female
  • Glaucoma / surgery*
  • Glaucoma, Open-Angle / surgery
  • Humans
  • Intraocular Pressure
  • Intraoperative Complications
  • Male
  • Middle Aged
  • Mitomycin / therapeutic use
  • Phacoemulsification / methods
  • Postoperative Complications
  • Retrospective Studies
  • Sclera / surgery*
  • Surgical Flaps*
  • Trabeculectomy / adverse effects
  • Trabeculectomy / methods*
  • Treatment Outcome

Substances

  • Mitomycin